Proapoptotic BID is required for myeloid homeostasis and tumor suppression

Genes and Development

Volumn 17, Issue 2, 2003, Pages 229-239

  Zinkel, Sandra S ^a   Ong, Christy C ^a   Ferguson, David O ^b   Iwasaki, Hiromi ^c   Akashi, Koichi ^c   Bronson, Roderick T ^c   Kutok, Jeffery L ^c   Alt, Frederick W ^b   Korsmeyer, Stanley J ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; BCL 2; BID; Cancer; Fas; Myeloid

Indexed keywords

CD34 ANTIGEN; DACTINOMYCIN; FAS ANTIGEN; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CHRONIC LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARRIER PROTEINS; CHROMOSOME ABERRATIONS; FEMALE; HOMEOSTASIS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOPOIESIS; MYELOPROLIFERATIVE DISORDERS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0037439151     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1045603     Document Type: Article

References (45)

1. Adams, J.M. and Cory, S. 1998. The Bcl-2 protein family: Arbiters of cell survival. Science 281: 1322-1326.
2. Bouillet, P., Metcalf, D., Huang, D.C., Tarlinton, D.M., Kay, T.W., Kontgen, F., Adams, J.M., and Strasser, A. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738.
3. Bouillet, P., Purton, J.F., Godfrey, D.I., Zhang, L.C., Coultas, L., Puthalakath, H., Pellegrini, M., Cory, S., Adams, J.M., and Strasser, A. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415: 922-926.
4. Cheng, E.H., Wei, M.C., Weiler, S., Flavell, R.A., Mak, T.W., Lindsten, T., and Korsmeyer, S.J. 2001. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8: 705-711.
5. Degenhardt, K., Chen, G., Lindsten, T., and White, E. 2002. BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell 2: 193-203.
6. Deguchi, K. and Gilliland, D.G. 2002. Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML. Leukemia 16: 740-744.
7. Domen, J., Cheshier, S.H., and Weissman, I.L. 2000. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J. Exp. Med. 191: 253-264.
8. Gross, A., McDonnell, J.M., and Korsmeyer, S.J. 1999a. BCL-2 family members and the mitochondria in apoptosis. Genes & Dev. 13: 1899-1911.
9. Gross, A., Yin, X.M., Wang, K., Wei, M.C., Jockel, J., Milliman, C., Erdjument-Bromage, H., Tempst, P., and Korsmeyer, S.J. 1999b. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274: 1156-1163.
10. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D., and Korsmeyer, S.J. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336.
11. Kataoka, T., Budd, R.C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M., et al. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10: 640-648.
12. Kelly, L.M. and D.G. Gilliland. 2002. Genetics of myeloid leukemias. Annu. Rev. Genomics Hum. Genet. 3: 179-198.
13. Klefstrom, J., Verschuren, E.W., and Evan, G. 2002. c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway. J. Biol. Chem. 277: 43224-43232.
14. Knudson, C.M., Tung, K.S., Tourtellotte, W.G., Brown, G.A., and Korsmeyer, S.J. 1995. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96-99.
15. Lagasse, E. and Weissman, I.L. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89: 1021-1031.
16. Land, H., Parada, L.F., and Weinberg, R.A. 1983. Cellular oncogenes and multistep carcinogenesis. Science 222: 771-778.
17. Letai, A., Bassik, M., Walensky, L., Sorcinelli, M., Weiler, S., and Korsmeyer, S. 2002. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183.
18. Li, H., Zhu, H., Xu, C.J., and Yuan, J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
19. Lindsten, T., Ross, A.J., King, A., Zong, W.X., Rathmell, J.C., Shiels, H.A., Ulrich, E., Waymire, K.G., Mahar, P., Frauwirth, K., et al. 2000. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6: 1389-1399.
20. Liyanage, M., Coleman, A., du Manoir, S., Veldman, T., McCormack, S., Dickson, R.B., Barlow, C., Wynshaw-Boris, A., Janz, S., Wienberg, J., et al. 1996. Multicolour spectral karyotyping of mouse chromosomes. Nat. Genet. 14: 312-315.
21. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490.
22. McDonnell, T.J., Deane, N., Platt, F.M., Nunez, G., Jaeger, U., McKearn, J.P., and Korsmeyer, S.J. 1989. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79-88.
23. McDonnell, T.J. and Korsmeyer, S.J. 1991. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349: 254-256.
24. McLemore, M.L., Grewal, S., Liu, F., Archambault, A., Poursine-Laurent, J., Haug, J., and Link, D.C. 2001. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14: 193-204.
25. Meijerink, J.P., Mensink, E.J., Wang, K., Sedlak, T.W., Sloetjes, A.W., de Witte, T., Waksman, G., and Korsmeyer, S.J. 1998. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood 91: 2991-2997.
26. Nakano, K. and Vousden, K.H. 2001. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7: 683-694.
27. Perlman, H., Pagliari, L.J., Georganas, C., Mano, T., Walsh, K., and Pope, R.M. 1999. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fasmediated apoptosis. J. Exp. Med. 190: 1679-1688.
28. Puthalakath, H., Huang, D.C., O'Reilly, L.A., King, S.M., and Strasser, A. 1999. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3: 287-296.
29. Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J.C., and Perucho, M. 1997. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969.
30. Rebel, V.I., Dragowska, W., Eaves, C.J., Humphries, R.K., and Lansdorp, P.M. 1994. Amplification of Sca-1+ Lin- WGA+ cells in serum-free cultures containing steel factor, interleu kin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood 83: 128-136.
31. Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S.J., Krammer, P.H., and Peter, M.E. 1999. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274: 22532-22538.
32. Schmitt, C.A., Fridman, J.S., Yang, M., Baranov, E., Hoffman, R.M., and Lowe, S.W. 2002. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1: 289-298.
33. Schneider, E., Moreau, G., Arnould, A., Vasseur, F., Khodabaccus, N., Dy, M., and Ezine, S. 1999. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice. Blood 94: 2613-2621.
34. Strijbosch, L.W., Buurman, W.A., Does, R.J., Zinken, P.H., and Groenewegen, G. 1987. Limiting dilution assays. Experimental design and statistical analysis. J. Immunol. Methods 97: 133-140.
35. Szilvassy, S.J., Humphries, R.K., Lansdorp, P.M., Eaves, A.C., and Eaves, C.J. 1990. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc. Natl. Acad. Sci. 87: 8736-8740.
36. Traver, D., Akashi, K., Weissman, I.L., and Lagasse, E. 1998. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 9: 47-57.
37. Vaux, D.L., Cory, S., and Adams, J.M. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
38. Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L., and Korsmeyer, S.J. 1996. BID: A novel BH3 domain-only death agonist. Genes & Dev. 10: 2859-2869.
39. Wei, M.C., Lindsten, T., Mootha, V.K., Weiler, S., Gross, A., Ashiya, M., Thompson, C.B., and Korsmeyer, S.J. 2000. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes & Dev. 14: 2060-2071.
40. Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross, A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B., and Korsmeyer, S.J. 2001. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730.
41. Yin, C., Knudson, C.M., Korsmeyer, S.J., and Van Dyke, T. 1997. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640.
42. Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K.A., and Korsmeyer, S.J. 1999. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886-891.
43. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S.J. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87: 619-628.
44. Zha, J., Weiler, S., Oh, K.J., Wei, M.C., and Korsmeyer, S.J. 2000. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290: 1761-1765.
45. Zong, W.X., Lindsten, T., Ross, A.J., MacGregor, G.R., and Thompson, C.B. 2001. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes & Dev. 15: 1481-1486.